Non-alcoholic fatty liver disease (NAFLD) progression to non-alcoholic steatohepatitis (NASH) and NASH-related hepatocellular carcinoma (HCC) evolves following a differential activation of endoplasmic reticulum stress responses

被引：0

作者：

Finnemore, Alexander ^{[1
]}

Maria Herranz, Jose ^{[1
,2
]}

Barace, Sergio ^{[1
]}

Infante, Stefany ^{[1
,3
]}

Avila, Matias A. ^{[1
,4
]}

Garcia-Porrero, Guillermo ^{[5
]}

Arcelus, Sara ^{[1
]}

Santamaria, Eva ^{[1
]}

Argemi, Josepmaria ^{[1
,4
,5
]}

机构：

[1] Ctr Invest Med Aplicada CIMA, Hepatol Program, Pamplona, Spain

[2] Ctr invest biomed red CIBER EHD, Pamplona, Spain

[3] Univ Piura Lima campus, Miraflores, Peru

[4] Inst Invest Navarra IdisNA, Navarra, Spain

[5] Univ Navarra Clin, Liver Unit, Pamplona, Spain

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT064

引用

页码：S697 / S697

页数：1

共 50 条

[31] Non-Alcoholic Steatohepatitis (NASH) as a Risk Factor in Hepatocellular Carcinoma (HCC) Development
Clark, Samantha
Zuk, Eric
Kim, Yestle
Gish, Robert
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 563 - 563
[32] Screening of non-alcoholic steatohepatitis (NASH)-related datasets and identification of NASH-related genes
Liu, Ming-Jiang
Jin, Hu
Chen, Yu-Bing
Yu, Jing-Jing
Guo, Zhen-Ya
He, Song-Qing
Zeng, Yong-Lian
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2021, 14 (05): : 567 - 581
[33] Liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH)
Miette, Veronique
Fournier, Celine
Adara, Linda
Sandrin, Laurent
2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6, 2007, : 1333 - 1336
[34] Predictive Value of ALT for Diagnosing Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
Verma, Siddharth
Sharma, Prashant
Hart, John
Mohanty, Smruti R.
GASTROENTEROLOGY, 2012, 142 (05) : S1019 - S1020
[35] HLA Class II Alleles Are Strongly Associated with Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Fibrosis
Karrar, Azza
Li, Zheng
Moosvi, Ali M.
Hariharan, Siddharth
Fang, Yun
Stepanova, Maria
Goodman, Zachary D.
Younossi, Zobair
HEPATOLOGY, 2014, 60 : 601A - 602A
[36] Independent Predictors of Non-alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in a Large Cohort of Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
Fang, Yun
Rafiq, Nila
Afendy, Mariam
Younossi, Youssef
Lam, Brian
Goodman, Zachary
Younossi, Zobair
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S120 - S120
[37] Components of Metabolic Syndrome and the Rising Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States
Stepanova, Maria
Afendy, Mariam
Vernon, Gregory C.
Nader, Fatema
Younossi, Zobair M.
GASTROENTEROLOGY, 2011, 140 (05) : S988 - S988
[38] Melanocortins and Interleukins Contributing to Advanced Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in Patients With BMI ≥ 40
Baranova, Ancha
Jarrar, Mohammed
Moazzez, Amir H.
Elariny, Hazem
Abawi, Massih
Wang, Lei
Afendy, Arian
Stepanova, Maria
Estep, J. M.
Younossi, Zobair M.
OBESITY, 2011, 19 : S87 - S87
[39] LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) COMPARED TO NON-NASH PATIENTS
Sadler, Erin
Mehta, Neil
Bhat, Mamatha
Ghanekar, Anand
Greig, Paul
Grant, David
Yao, Francis
Sapisochin, Gonzalo
TRANSPLANT INTERNATIONAL, 2017, 30 : 93 - 93
[40] LEAN AND OBESE PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) / NON-ALCOHOLIC FATTY LIVER DISEASE (NALFD); COMPARISONS OF POPULATIONS AND DISEASE PROGRESSION
Lai, M.
Frick, A.
Haubrich, R.
Koch, B.
Milligan, S.
Natha, M.
Radtchenko, J.
Younossi, Z.
Afdhal, N.
VALUE IN HEALTH, 2020, 23 : S143 - S143

← 1 2 3 4 5 →